Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Patient Portal Software Market PowerPoint Presentation
Download Presentation
Patient Portal Software Market

Patient Portal Software Market

0 Views Download Presentation
Download Presentation

Patient Portal Software Market

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. ASSISTIVE REPRODUCTIVE TECHNOLOGY MARKET ANALYSIS • Assistive Reproductive Technology Market, by Product Type (Consumables  and Instruments), by Technology (In-vitro fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER) and Others); by Procedure (Fresh Donor, Frozen Donor, Fresh Nondonor, Frozen Nondonor, Embryo/Egg Banking, and Others; by End User (Fertility Clinics, IVF Center, and Hospital), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027

  3. Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory. These eggs are then mixed with sperms to form embryos. ART procedure sometimes uses donor eggs, donor sperm, or previously frozen embryos. It may involve a surrogate or gestational carrier. • Rising prevalence and incidence of infertility is expected to drive global assistive reproductive technology market growth in the forecast period • Rising prevalence of infertility has led to an increase in demand for fertility treatments such as In Vitro Fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI) and others. In the U.S. prevalence of infertility is rising rapidly. For instance, according to the U.S. Department of Health & Human Services, in 2016, around 10 in 100 (6.1 million) women faced difficulty in getting pregnant. • In past few years there has been significant preference for assistive reproductive technology owing to rising prevalence and incidence of infertility in men and women. For instance, according to the University of Pittsburgh Medical Center (UPMC Pinnacle), around seven million men and women opted for assisted fertility treatments such as IVF in 2015. Moreover, according to the Society for Assisted Reproductive Technology, in 2013, around 175,000 cycles of IVF were conducted, which was a 6% increase compared to 2012. • Such rising prevalence and incidence of infertility had led to an increase in number of assistive reproductive technology (ART) clinics in the U.S. According to the National Centers for Chronic Disease Prevention and Health Promotion, there are total 499 ART clinics in U.S, among which, 464 clinics had reported the ART related data, and in 2015 total 231,936 ART cycles are performed in U.S.

  4. Increasing demand of assistive reproductive technology, has increased the participation of manufacturers in the development of assistive reproductive technology products • Market players are focused on expanding their portfolio of reproductive and fertility treatment products. For instance, Cooper Surgical Inc., a provider of fertility & genomic solutions, has an extensive portfolio ART management systems, IVF workstations, pipettes and needles for sperm or eggs transfer, catheters for embryos transfer, culture media and test kits. Moreover, Hamilton Thorne, In., also provides products such as sperm analyzers and a broad range of ART micropipettes. • FUJIFILM Irvine Scientific, Inc. provides water for assisted reproductive technology use, and also provides various products required for ART procedures. Moreover, GonagenMedikal also offers various assistive reproductive technology such as IVF, ICSI and others, for infertility treatment. • Companies are also adopting strategies to increase their share in the global assistive reproductive technology market and improve their product portfolio. For instance, in June 2018, Vitrolife AB and GE Healthcare partnered to improve their assisted reproductive technology offerings in the market.

  5. Manufacturers are also engaged in creating awareness regarding In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection(ISCI) which are expected to propel the global assistive reproductive technology market growth • Manufactures are taking several initiatives for creating awareness and providing training regarding ART technology. For instance, in June 2019 Cooper Surgical Inc. Conducted a workshop in India, to provide complete insight about the pre-requisites and techniques associated with ART, this workshop included lectures, demonstration, and hands-on work training of ART technologies. Moreover, in March 2019 Cooper Surgical Inc., conducted a workshop in Denmark on sperm selection techniques for ICSI procedures. • Global assistive reproductive technology market size was valued at US$ 23,669.2 Mn in 2018, and is expected to witness a CAGR of 5.3% during the forecast period (2019–2027). • North America is expected to hold dominant position in global assistive reproductive technology market, due to increasing awareness about fertility treatments, and rising number of hospitals, and ART procedures. For instance, in U.S. 2015 according to National Center For Chronic Disease Prevention and Health Promotion, approximately 38.1% of  ART procedures were carried out for age group <35 yrs., and 21.0 % procedures are performed for people in the age group of 35 to 37 years. Such increasing demand for ART procedures is expected to drive the global assistive reproductive technology market growth. • Furthermore, Europe is expected to witness considerable growth in the global assistive reproductive technology market due to increasing number of ART cycles. For instance, in 2014 according to the European society of Human Reproduction and Embryology (ESHRE), around 800,000 treatment cycles were performed from 39 countries in Europe.

  6. Market Restraints • Factors restraining the global assistive reproductive technology market growth are availability of alternative treatment such as hormone therapy including hormone injections and tablets such as Choragon, Gonapeptyl, Lutinus, Propess and others. • Key Players • Key players operating in the global assistive reproductive technology market include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtechApS, GonagenMedikal, Cook Medical LLC., and CellCura ASA.

  7. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/assistive-reproductive-technology-market-3041

  8. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  9. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  10. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/